Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion type Assertion NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_head.
- NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion description "[Ex vivo pretreatment of BMC from patients with ICMP with AVE significantly increased eNOS mRNA expression by 2.1-fold (P < 0.05) and eNOS activity as assessed by ESR by >3-fold (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_provenance.
- NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion evidence source_evidence_literature NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_provenance.
- NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion SIO_000772 16983080 NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_provenance.
- NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion wasDerivedFrom befree-2016 NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_provenance.
- NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_assertion wasGeneratedBy ECO_0000203 NP569943.RAb8zHy-zAzFoUSwgXnu9R8mue15_iXX29HZqaRv8olMc130_provenance.